GILEAD SCIENCES, INC. Long-Term Concentrated

Location: Foster City, CA

CIK: 0000882095 · Show all filings

Period: Q3 2025 (← Previous) (Next →)

Filing Date: Nov 13, 2025

Total Value: $1.791B (100.0% shares, 0.0% debt)

Holdings (9)

GLPG GALAPAGOS NV 32.3%

Value $579M Shares 16,707,477 Est. Cost $27.64 Unrealized —

ACLX ARCELLX INC 30.8%

Value $552M Shares 6,720,803 Est. Cost $86.39 Unrealized -16.7%

RCUS ARCUS BIOSCIENCES INC 23.9%

Value $427M Shares 31,424,760 Est. Cost $16.13 Unrealized -35.5%

ASMB ASSEMBLY BIOSCIENCES INC 6.4%

Value $115M Shares 4,505,391 Est. Cost $19.07 Unrealized +15.0%

— MERUS N V 2.4%

Value $42.61M Shares 452,527 Est. Cost $42.05 Unrealized —

TNGX TANGO THERAPEUTICS INC 2.3%

Value $40.78M Shares 4,854,443 Est. Cost $4.64 Unrealized +45.8%

KYTX KYVERNA THERAPEUTICS INC 1.4%

Value $24.76M Shares 4,126,119 Est. Cost $4.79 Unrealized -16.6%

XLO XILIO THERAPEUTICS INC 0.4%

Value $7.673M Shares 9,105,451 Est. Cost $0.98 Unrealized -27.2%

CYPH LEAP THERAPEUTICS INC 0.1%

Value $2.415M Shares 5,319,148 Est. Cost $2.97 Unrealized -89.4%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
GLPG	GALAPAGOS NV	16,707,477	$579M	32.3%	$27.64	—	SPON ADR	36315X101
ACLX	ARCELLX INC	6,720,803	$552M	30.8%	$86.39	-16.7%	COMMON STOCK	03940C100
RCUS	ARCUS BIOSCIENCES INC	31,424,760	$427M	23.9%	$16.13	-35.5%	COM	03969F109
ASMB	ASSEMBLY BIOSCIENCES INC	4,505,391	$115M	6.4%	$19.07	+15.0%	COM NEW	045396207
—	MERUS N V	452,527	$42.61M	2.4%	$42.05	—	COM	N5749R100
TNGX	TANGO THERAPEUTICS INC	4,854,443	$40.78M	2.3%	$4.64	+45.8%	COM	87583X109
KYTX	KYVERNA THERAPEUTICS INC	4,126,119	$24.76M	1.4%	$4.79	-16.6%	COM	501976104
XLO	XILIO THERAPEUTICS INC	9,105,451	$7.673M	0.4%	$0.98	-27.2%	COM	98422T100
CYPH	LEAP THERAPEUTICS INC	5,319,148	$2.415M	0.1%	$2.97	-89.4%	COM NEW	52187K200